Rosenblum Silverman Sutton S F Inc Guardant Health, Inc. Transaction History

Rosenblum Silverman Sutton S F Inc

  • $376 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$28.82 - $77.35 $78,102 - $209,618
-2,710 Reduced 11.08%
21,745 $877,000
Q1 2022

May 13, 2022
SELL
$48.25 - $100.49 $55,970 - $116,568
-1,160 Reduced 4.53%
24,455 $1.62 Million
Q4 2021

Feb 14, 2022
BUY
$88.71 - $120.43 $2.27 Million - $3.08 Million
25,615 New
25,615 $2.56 Million

Others Institutions Holding GH

# of Institutions
323
Shares Held
127M
Call Options Held
844K
Put Options Held
2.38M
View Full List

About Guardant Health, Inc.

GH Quotes by TradingView
  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.75B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Rosenblum Silverman Sutton S F Inc Portfolio

Follow Rosenblum Silverman Sutton S F Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenblum Silverman Sutton S F Inc , based on Form 13F filings with the SEC.

News

Stay updated on Rosenblum Silverman Sutton S F Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email